Role of Biofilms in Children with Chronic Adenoiditis and Middle Ear Disease

Sara Torretta1,2, Lorenzo Drago3,4, Paola Marchisio5,6

  • 1Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Policlinico of Milan, Via Francesco Sforza, 35, 20122 Milano, Italy. sara.torretta@unimi.it.

Insights

Bacterial biofilms may explain why antibiotics fail for chronic adenoiditis in children, potentially leading to chronic middle ear infections and hearing issues. This review explores biofilm involvement in these conditions.

Area of Science:

  • Pediatric Otolaryngology
  • Microbiology
  • Infectious Diseases

Background:

  • Chronic adenoiditis is common in children and often leads to recurrent or chronic middle ear diseases.
  • These conditions can cause long-term hearing impairment and functional sequelae.
  • Surgical intervention is common for children unresponsive to antibiotic therapy.

Purpose of the Study:

  • To review current evidence on the role of bacterial biofilms in chronic adenoiditis.
  • To investigate the link between biofilms, chronic adenoiditis, and associated middle ear infections in children.

Main Methods:

  • Literature review of existing studies on bacterial biofilms.
  • Analysis of research concerning chronic adenoiditis and pediatric middle ear infections.
  • Synthesis of evidence linking nasopharyngeal biofilms to disease development.

Main Results:

  • Antibiotic treatment failure in chronic adenoiditis may be linked to nasopharyngeal bacterial biofilms.
  • Biofilms are implicated in the development of chronic nasopharyngeal inflammation.
  • These biofilms may contribute to the occurrence of chronic or recurrent middle ear disease.

Conclusions:

  • Bacterial biofilms are a significant factor in the pathogenesis of chronic adenoiditis.
  • Understanding biofilm involvement could lead to improved treatment strategies for pediatric adenoiditis and middle ear infections.
  • Further research into biofilm-based therapies is warranted for affected children.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.4K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
612
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
598
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.3K